Market Cap 206.65M
Revenue (ttm) 20.22M
Net Income (ttm) -30.22M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -149.46%
Debt to Equity Ratio 0.00
Volume 10,100
Avg Vol 62,766
Day's Range N/A - N/A
Shares Out 10.81M
Stochastic %K 61%
Beta 0.32
Analysts Strong Sell
Price Target $30.67

Company Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx for the treatment of chronic wounds and ot...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 7 797 14100
Fax: 972 7 797 14111
Address:
42 Hayarkon Street, Yavne, Israel
Greenpa
Greenpa Jun. 28 at 7:19 PM
$MDWD Tic toc… ample funding, massive KOL support, superior wound prep data, BARDA funding of US manufacturing and below $20 presents a 5x to 10x plus opportunity unlike any other in the biopharma space. The biggest “risk” is that they sell to one of the partners too quickly. EschatEx will likely quickly displace Santyl in a $700M plus market starting at some point in 2026. I’m hoping that they stay independent, but I would take a quick $60 per share….
1 · Reply
Spammified
Spammified Jun. 20 at 6:14 PM
$MDWD I'll bite 🥞
0 · Reply
JohnPDaly
JohnPDaly Jun. 19 at 12:05 PM
$LCTX $MDWD https://x.com/us_fda/status/1935508321559019914?s=12
0 · Reply
JohnPDaly
JohnPDaly Jun. 16 at 12:18 PM
$MDWD always bet on man’s inhumanity to Man.
0 · Reply
Sukhavati
Sukhavati Jun. 15 at 4:57 PM
$MDWD nice, cheaper shares
0 · Reply
z06forum
z06forum Jun. 13 at 10:46 AM
$MDWD hmm guess they will need more Burn patches now that Israel has bombed Iran..
0 · Reply
JohnPDaly
JohnPDaly Jun. 3 at 3:45 PM
$LCTX $INMB $$MDWD “The fewer men, the greater share of honour.” Henry V.
1 · Reply
JohnPDaly
JohnPDaly Jun. 2 at 5:13 PM
$MDWD I am assuming they have all those clinical study partners in order to create a bidding war after interim data is complete in 2026.
1 · Reply
JohnPDaly
JohnPDaly Jun. 2 at 11:56 AM
$LCTX $MDWD $INMB https://x.com/learnbiotech/status/1929478329595302110?s=12
3 · Reply
PenkeTrading
PenkeTrading May. 31 at 1:39 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Mediwound Ltd. Is that bullish or bearish? $MDWD #Mediwound #RsiOverbought #NASDAQ
0 · Reply
Latest News on MDWD
MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript

May 21, 2025, 12:46 PM EDT - 6 weeks ago

MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript


MediWound Ltd.: Undervalued High-Growth Potential

May 16, 2025, 10:34 AM EDT - 7 weeks ago

MediWound Ltd.: Undervalued High-Growth Potential


MediWound to Report First Quarter 2025 Financial Results

May 5, 2025, 8:00 AM EDT - 2 months ago

MediWound to Report First Quarter 2025 Financial Results


MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 12:10 PM EDT - 3 months ago

MediWound Ltd. (MDWD) Q4 2024 Earnings Call Transcript


MediWound to launch Phase III trial for venous leg ulcers

Feb 12, 2025, 8:12 AM EST - 5 months ago

MediWound to launch Phase III trial for venous leg ulcers


MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript

Nov 26, 2024, 1:46 PM EST - 7 months ago

MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript


MediWound Is A Healthy Investment

Oct 29, 2024, 10:49 AM EDT - 8 months ago

MediWound Is A Healthy Investment


MediWound Ltd. (MDWD) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 3:00 PM EDT - 11 months ago

MediWound Ltd. (MDWD) Q2 2024 Earnings Call Transcript


MediWound to Report Second Quarter 2024 Financial Results

Aug 2, 2024, 8:00 AM EDT - 1 year ago

MediWound to Report Second Quarter 2024 Financial Results


MediWound Ltd. (MDWD) Q1 2024 Earnings Call Transcript

May 29, 2024, 11:35 AM EDT - 1 year ago

MediWound Ltd. (MDWD) Q1 2024 Earnings Call Transcript


MediWound to Report First Quarter 2024 Financial Results

May 22, 2024, 8:00 AM EDT - 1 year ago

MediWound to Report First Quarter 2024 Financial Results


MediWound Ltd. (MDWD) Q4 2023 Earnings Call Transcript

Mar 21, 2024, 11:35 AM EDT - 1 year ago

MediWound Ltd. (MDWD) Q4 2023 Earnings Call Transcript


MediWound Ltd. (MDWD) Q3 2023 Earnings Call Transcript

Nov 21, 2023, 1:14 PM EST - 1 year ago

MediWound Ltd. (MDWD) Q3 2023 Earnings Call Transcript


MediWound to Report Third Quarter 2023 Financial Results

Nov 14, 2023, 8:02 AM EST - 1 year ago

MediWound to Report Third Quarter 2023 Financial Results


MediWound Deploys NexoBrid® for Emergency Supply

Oct 9, 2023, 7:34 AM EDT - 1 year ago

MediWound Deploys NexoBrid® for Emergency Supply


MediWound Ltd. (MDWD) Q2 2023 Earnings Call Transcript

Aug 16, 2023, 1:49 PM EDT - 2 years ago

MediWound Ltd. (MDWD) Q2 2023 Earnings Call Transcript


Greenpa
Greenpa Jun. 28 at 7:19 PM
$MDWD Tic toc… ample funding, massive KOL support, superior wound prep data, BARDA funding of US manufacturing and below $20 presents a 5x to 10x plus opportunity unlike any other in the biopharma space. The biggest “risk” is that they sell to one of the partners too quickly. EschatEx will likely quickly displace Santyl in a $700M plus market starting at some point in 2026. I’m hoping that they stay independent, but I would take a quick $60 per share….
1 · Reply
Spammified
Spammified Jun. 20 at 6:14 PM
$MDWD I'll bite 🥞
0 · Reply
JohnPDaly
JohnPDaly Jun. 19 at 12:05 PM
$LCTX $MDWD https://x.com/us_fda/status/1935508321559019914?s=12
0 · Reply
JohnPDaly
JohnPDaly Jun. 16 at 12:18 PM
$MDWD always bet on man’s inhumanity to Man.
0 · Reply
Sukhavati
Sukhavati Jun. 15 at 4:57 PM
$MDWD nice, cheaper shares
0 · Reply
z06forum
z06forum Jun. 13 at 10:46 AM
$MDWD hmm guess they will need more Burn patches now that Israel has bombed Iran..
0 · Reply
JohnPDaly
JohnPDaly Jun. 3 at 3:45 PM
$LCTX $INMB $$MDWD “The fewer men, the greater share of honour.” Henry V.
1 · Reply
JohnPDaly
JohnPDaly Jun. 2 at 5:13 PM
$MDWD I am assuming they have all those clinical study partners in order to create a bidding war after interim data is complete in 2026.
1 · Reply
JohnPDaly
JohnPDaly Jun. 2 at 11:56 AM
$LCTX $MDWD $INMB https://x.com/learnbiotech/status/1929478329595302110?s=12
3 · Reply
PenkeTrading
PenkeTrading May. 31 at 1:39 PM
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Mediwound Ltd. Is that bullish or bearish? $MDWD #Mediwound #RsiOverbought #NASDAQ
0 · Reply
Sukhavati
Sukhavati May. 31 at 8:29 AM
$MDWD what buyout price target do you guys have/expect? I am buying every month, still building a position, but damn is the price going high without stopping
1 · Reply
JohnPDaly
JohnPDaly May. 30 at 8:11 PM
$MDWD Well done.
0 · Reply
jwon3
jwon3 May. 22 at 5:50 PM
$MDWD Potential acquirer should step in before EUR13.75 million equity investment from the European Innovation Council Accelerator gets materialized.
2 · Reply
JarvisFlow
JarvisFlow May. 22 at 11:30 AM
HC Wainwright & Co. has adjusted their stance on MediWound ( $MDWD ), setting the rating to Buy with a target price of 25 → 31.
0 · Reply
Estimize
Estimize May. 21 at 10:12 PM
$MDWD reported -0.07 EPS and 4.96 revenue for Q1. http://www.estimize.com/intro/mdwd?chart=historical&metric_name=eps&utm_content=MDWD&utm_
0 · Reply
Dr_Adis1983
Dr_Adis1983 May. 21 at 6:32 PM
$VVOS so $MDWD put out earnings of $4MILL this morning for Q1. Their market cap is $250MILL. We have similar earnings and market cap of $10MILL. What am I missing here?
0 · Reply
JohnPDaly
JohnPDaly May. 21 at 1:25 PM
$MDWD all systems go. Hopefully some clarity on the US plant this fall. Never had a company where the federal government is going to fund the building of a facility.
0 · Reply
DonCorleone77
DonCorleone77 May. 21 at 11:09 AM
$MDWD MediWound sees FY25 revenue $24M, consensus $23.97M
0 · Reply
DonCorleone77
DonCorleone77 May. 21 at 11:08 AM
$MDWD MediWound reports Q1 EPS (7c), consensus (66c) Reports Q1 revenue $4M, consensus $5.2M. "We entered 2025 with strong execution across our clinical, commercial, and operational priorities, maintaining the momentum established in 2024," said Ofer Gonen, Chief Executive Officer of MediWound. "The VALUE Phase III study for EscharEx remains on schedule, and our additional collaboration with Kerecis marks a significant milestone-bringing nearly all leading global wound care companies into our clinical research programs. Meanwhile, NexoBrid continues to gain global traction, as we advance strategic manufacturing investments to support sustained, long-term growth."
0 · Reply
biotechNorway
biotechNorway May. 20 at 3:56 PM
$MDWD If you listened to the KOL session from the start of the year and have even basic reasoning skills, you’d likely have at least 5% of your portfolio in $MDWD by now. Unfortunately, most average investors won’t spend an hour on a presentation that could change their financial future. https://lifescievents.com/event/mediwound/
0 · Reply
JohnPDaly
JohnPDaly May. 15 at 8:53 PM
SEC Filing | MediWound $MDWD locked and loaded. https://ir.mediwound.com/node/11756/html
0 · Reply
JohnPDaly
JohnPDaly May. 15 at 4:30 PM
$MDWD The Calm before the Calm.
0 · Reply